Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-06-13, Stock:JNJ, The news for the past five days is as follows:
2018-06-06: NEWS1: J&J gets $2.7 billion offer for sterilization unit from Fortive.NEWS2: J&J gets $2.7 bln offer for sterilization unit from Fortive.NEWS3: In Missouri, J&J faces biggest trial yet alleging talc caused cancer.NEWS4: J&J to sell sterilization unit to Fortive for $2.7 billion.NEWS5: Fortive to acquire Johnson & Johnson sterilization business for $2.7 billion.NEWS6: Fortive offers $2.7 bln for J&J unit's sterilization business.NEWS7: Johnson & Johnson Announces Binding Offer from Fortive Corporation to Acquire Advanced Sterilization Products (ASP).NEWS8: Noteworthy Wednesday Option Activity: JNJ, LW, CPB.NEWS9: Noteworthy Wednesday Option Activity: JNJ, LW, CPB.NEWS10: Corrections & Amplifications.NEWS11: Fortive Offers To Buy J&J's Advance Sterilization Product Biz For $2.8 Bln.NEWS12: Fortive Offers To Buy J&J's Advance Sterilization Product Biz For $2.8 Bln.NEWS13: Boston U. boosts lung cancer research with Johnson & Johnson.NEWS14: The Top 4 UPS Shareholders (UPS).NEWS15: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS16: J&J Faces High-Stakes Trial Over 22 Women's Talc Claims.NEWS17: J&J Facing High-Stakes Talc Trial Over 22 Women's Cancer Claims.NEWS18: Is an Acquisition in Portola Pharmaceuticals' Future?.NEWS19: Is an Acquisition in Portola Pharmaceuticals' Future?.NEWS20: Is an Acquisition in Portola Pharmaceuticals&apos; Future?.
2018-06-07: NEWS1: Cramer: Don't be afraid to pay up for best-of-breed stock....NEWS2: Mixed finish for stocks as energy rises and tech drops.NEWS3: Mixed finish for stocks as energy rises and tech drops.NEWS4: Fortive offers $2.7 billion to buy Johnson & Johnson&apos;s medical-equipment sterilization business.NEWS5: The Robotic Surgery Revolution Is Just Getting Started.NEWS6: Stocks are mixed as energy companies rise; tech stocks drop.NEWS7: Allergan on an upswing, Vail Resorts soars, Johnson & Johnson dips.NEWS8: J&J Receives Buyout Offer for Sterilization Products Unit.NEWS9: J&J Receives Buyout Offer for Sterilization Products Unit.NEWS10: Fortive Plans to Buy Johnson & Johnson's Sterilization Unit.NEWS11: Fortive Plans to Buy Johnson & Johnson's Sterilization Unit.NEWS12: Allergan, Vail Resorts and Johnson & Johnson are the Yahoo Finance charts of the day..NEWS13: China will see the biggest boost in World Cup ad dollars – even though it didn’t qualify.NEWS14: China will see the biggest boost in World Cup ad dollars – even though it didn’t qualify.NEWS15: Stocks edge higher as oil price gains boost energy companies.NEWS16: J&J Receives Buyout Offer for Sterilization Products Unit.NEWS17: Stocks to Watch: Boeing, Tesla, Allergan, Amazon, Alibaba, Smucker.NEWS18: Stocks making the biggest moves premarket: SJM, THO, FIVE, UNFI, ZS, AGN, JNJ, TRUE & more.NEWS19: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS20: Benzinga's Daily Biotech Pulse: Johnson & Johnson to Dispose Sterilization Products Business, Mixed Results From Protesostasis' Cystic Fibrosis Study.NEWS21: [$$] Fortive Offers $2.7 Billion for J&J's Medical-Equipment Sterilization Business.
2018-06-08: NEWS1: Bourdain, Spade suicides highlight need for new depression drugs.NEWS2: 3 Dividend Stocks Perfect for Retirees.NEWS3: 3 Dividend Stocks Perfect for Retirees.NEWS4: J&J Exec Makes First Microsoft Insider Stock Buy Since 2015.NEWS5: Dow Movers: AAPL, PG.NEWS6: Dow Movers: AAPL, PG.NEWS7: Dying Patients Seeking Drugs Face Reality Check on Right to Try.NEWS8: Better Buy: GlaxoSmithKline plc vs. Johnson & Johnson.NEWS9: Better Buy: GlaxoSmithKline plc vs. Johnson & Johnson.NEWS10: 3 Dividend Stocks Perfect for Retirees.NEWS11: Better Buy: GlaxoSmithKline plc vs. Johnson & Johnson.NEWS12: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS13: Asian shares fall ahead of G7 summit, central bank meetings.
2018-06-11: NEWS1: Better Buy: Verizon Communications Inc. vs. Johnson & Johnson.NEWS2: Better Buy: Verizon Communications Inc. vs. Johnson & Johnson.NEWS3: Better Buy: Verizon Communications Inc. vs. Johnson & Johnson.NEWS4: Investors ready to resuscitate Johnson & Johnson's ailing stock.NEWS5: Dow Movers: MCD, CSCO.NEWS6: Dow Movers: MCD, CSCO.NEWS7: Notable ETF Inflow Detected - ACWI, JPM, XOM, JNJ.NEWS8: Notable ETF Inflow Detected - ACWI, JPM, XOM, JNJ.
2018-06-12: NEWS1: AI And Robotics Are Taking Robotic Surgery To New Levels.NEWS2: [$$] Iqvia? Its CEO Was the Highest Paid Pharma Chief.NEWS3: [$$] Johnson & Johnson Accepts Platinum Equity's $2.1 Billion Offer for LifeScan Business.NEWS4: J&J Formally Accepts $2.1 Billion Offer for Diabetes Device Unit.NEWS5: J&J Formally Accepts $2.1 Billion Offer for Diabetes Device Unit.NEWS6: J&J accepts $2.1 billion bid for its LifeScan diabetes business.NEWS7: J&J accepts $2.1 billion offer for its LifeScan unit.NEWS8: Why Dow&apos;s J&J May Try To Sweep Boston Scientific From Stryker.NEWS9: J&J accepts $2.1 bln offer for its LifeScan unit.NEWS10: Johnson & Johnson accepts $2.1B deal for LifeScan business.NEWS11: Johnson & Johnson Announces Acceptance of Binding Offer From Platinum Equity To Acquire LifeScan, Inc..NEWS12: Johnson & Johnson Accepts Platinum Equity's Offer To Buy LifeScan For $2.1 Bln.NEWS13: Johnson & Johnson Accepts Platinum Equity's Offer To Buy LifeScan For $2.1 Bln.NEWS14: Amgen Gets FDA Nod to Add ASPIRE Data on Kyprolis Label.NEWS15: Amgen Gets FDA Nod to Add ASPIRE Data on Kyprolis Label.NEWS16: Lilly & AstraZeneca Scrap Studies on Alzheimer's Candidate.NEWS17: Lilly & AstraZeneca Scrap Studies on Alzheimer's Candidate.NEWS18: Alzheimer's Research Stumbles Again: What's the Road Ahead?.NEWS19: Alzheimer's Research Stumbles Again: What's the Road Ahead?.NEWS20: Lilly & AstraZeneca Scrap Studies on Alzheimer&apos;s Candidate.NEWS21: Stryker Likely to Acquire Boston Scientific, Shares Down.NEWS22: Stryker Likely to Acquire Boston Scientific, Shares Down.NEWS23: Amgen Gets FDA Nod to Add ASPIRE Data on Kyprolis Label.NEWS24: Alzheimer&apos;s Research Stumbles Again: What&apos;s the Road Ahead?.NEWS25: Stryker Likely to Acquire Boston Scientific, Shares Down.NEWS26: Pharma R&D Investments Moderating -- But Still High.NEWS27: Johnson & Johnson To Present At Goldman Sachs Conference; Webcast At 12:20 PM ET.NEWS28: Johnson & Johnson To Present At Goldman Sachs Conference; Webcast At 12:20 PM ET.NEWS29: [$$] AstraZeneca and Eli Lilly scrap Alzheimer’s drug trial.

Answer: Rise